阿托品在青少年近视防控中的应用

Application of Atropine in Prevention and Control of Myopia in Adolescents

近视是导致儿童青少年致盲的主要原因,目前全世界尚没有发现可以治愈近视的方法,但我们可以采取干预措施来预防或延缓近视的发生或进展,尽可能减少高度近视人群及其相关并发症,让更多的儿童青少年拥有视力,不致于发生失明。故寻找行之有效的近视防控措施十分必要,而低浓度阿托品作为延缓近视进展的主要药物,对其进行深入研究极其重要。该综述就低浓度阿托品滴眼液在延缓近视进展中的作用机制、临床应用及其不良反应进行详细阐述。

Myopia is the main cause of blindness among children and adolescents. At present, there is no method to cure myopia in the world, but we can take intervention measures to prevent or delay the occurrence or progress of myopia, reduce the number of people with high myopia and its related complications as much as possible, so that more children and adolescents can have vision without blindness. Therefore, it is necessary to find effective measures to prevent and control myopia. As the main drug to delay the progress of myopia, it is extremely important to conduct in-depth research on low concentration atropine. In this review, the mechanism, clinical application and adverse reactions of low concentration atropine eye drops in delaying the progress of myopia were described in detail.